KGRKJGETMRETU895U-589TY5MIGM5JGB5SDFESFREWTGR54TY
Server : Apache/2.4.62
System : FreeBSD fbsdweb2.web.rcn.net 14.1-RELEASE FreeBSD 14.1-RELEASE releng/14.1-n267679-10e31f0946d8 GENERIC amd64
User : www ( 80)
PHP Version : 8.3.8
Disable Function : NONE
Directory :  /domains/bluerae/clients/abs/pub/

Upload File :
current_dir [ Writeable ] document_root [ Writeable ]

 

Current File : /domains/bluerae/clients/abs/pub/presentations.html
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<title>Presentations: ABS Abt Bio-Pharma Solutions</title>
<script language="javascript" type="text/javascript" src="../scripts/scripts.js"></script>

<link href="../styles/styles.css" rel="stylesheet" type="text/css" />
</head>

<body onload="P7_autoHide('popupabout','popupadvantage','popupservices','popuppub','popupnews','popupcareers');MM_preloadImages('../images/thumb1_ovr.jpg','../images/thumb2_ovr.jpg','../images/thumb3_ovr.jpg','../images/ba_about.gif','../images/ba_advantage.gif','../images/ba_services.gif','../images/ba_pub.gif','../images/ba_news.gif','../images/ba_careers.gif')">

<div id="container">
<a name="top"></a>

<!--HEADER-->
 <div id="header" onmouseover="P7_autoLayers(0)"><p><a href="../index.html"><img src="../images/logo.gif" alt="ABS: Abt Bio-Pharma Solutions" width="284" height="85" id="logo" /></a><a href="../index.html">home</a> :: <a href="../about/our.html">contact us</a> :: <a href="../search/index.html">search</a> :: <a href="../sitemap/index.html">sitemap</a></p>
    <img src="../images/tagline.gif" alt="Real World. Real Value." width="240" height="20" class="tagline" />
</div>

<!--MAIN MENU-->
<div id="mainmenu"><img src="../images/menu_cap.gif" alt=" " onmouseover="P7_autoLayers(0)" /><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('about','','../images/ba_about.gif',1)"><img src="../images/b_about.gif" alt="About Us" name="about" width="81" height="35" border="0" id="about"  onmouseover="P7_autoLayers(0,'popupabout');P7_Snap('about','popupabout',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('advantage','','../images/ba_advantage.gif',1)"><img src="../images/b_advantage.gif" alt="ABS Advantage" name="advantage" width="123" height="35" border="0" id="advantage" onmouseover="P7_autoLayers(0,'popupadvantage');P7_Snap('advantage','popupadvantage',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('services','','../images/ba_services.gif',1)"><img src="../images/b_services.gif" alt="Services" name="services" width="81" height="35" border="0" id="services" onmouseover="P7_autoLayers(0,'popupservices');P7_Snap('services','popupservices',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('pub','','../images/ba_pub.gif',1)"><img src="../images/ba_pub.gif" alt="Publications &amp; Presentations" name="pub" width="221" height="35" border="0" id="pub" onmouseover="P7_autoLayers(0,'popuppub');P7_Snap('pub','popuppub',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('news','','../images/ba_news.gif',1)"><img src="../images/b_news.gif" alt="News &amp; Events" name="news" width="120" height="35" border="0" id="news" onmouseover="P7_autoLayers(0,'popupnews');P7_Snap('news','popupnews',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('careers','','../images/ba_careers.gif',1)"><img src="../images/b_careers.gif" alt="Careers" name="careers" width="80" height="35" border="0" id="careers" onmouseover="P7_autoLayers(0,'popupcareers');P7_Snap('careers','popupcareers',0,35)" /></a><img src="../images/menu_cap.gif" alt=" " /></div>
  
  <div id="sidebarleft"><div id="pagemenu">
    <ul>
      <li><a href="publications.html">Publications</a></li>
      <li><a href="presentations.html" class="selected">Presentations</a></li>
      <ul>
          <li><a href="#2008">2008</a></li>
          <li><a href="#2007">2007</a></li>
          <li><a href="#2006">2006</a></li>
          <li><a href="#2005">2005</a></li>
          <li><a href="#2004">2004</a></li>
        </ul>
    </ul>
  </div>
  </div>
  
  <!-- SIDEBAR -->
  <div id="sidebar"><form action="http://search.freefind.com/find.html" method="get" accept-charset="utf-8" target="_self">
      <p>
        <input type="hidden" name="si" value="49467390">
		<input type="hidden" name="pid" value="r">
		<input type="hidden" name="n" value="0">
		<input type="hidden" name="_charset_" value="">
		<input type="hidden" name="bcd" value="&#247;">
		<input type="text" name="query" class="searchfield" onfocus="clearText(this);clearStyle(this);" value="SEARCH" size="20"> 
        <input type="image" name="submit" id="submit" src="../images/go.gif" />      </p>
      </form><h1 class="sidebarhead">&nbsp;</h1>
      
      <ul class="sidebarlist">
        <li class="quote">&quot;The complex biopharma marketplace requires a comprehensive approach to commercialization.  We understand that, and have developed a holistic perspective that addresses an increasingly dynamic healthcare marketplace when designing research methodologies and interpreting result.&quot; </li>
      </ul>
      <p class="attribution">Nandini Hadker, Executive Director, Abt Bio-Pharma Solutions, Inc.</p>
  </div>

<!-- MAIN CONTENT -->  
  <div id="maincontent" class="prominentlinks">
    <h1>Presentations</h1>
    <p>The following are selected presentations of ABS Team Members:</p>
    <a name="2008"></a>
    <h2>2008</h2>
    <p>Miller JD, Denevich S, McGarry MJ, Albano
      MP, Caloyeras JP, Russell MW. <strong><a href="../downloads/Miller_ModelingImagingOct08.pdf">Modeling the fiscal impact of using perflutren lipid
        microspheres (PLM) for follow-up echocardiographic imaging.</a></strong> International Society for Pharmacoeconomics and
      Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
    <p>
  Ganz ML, Prasad M, Yeh YC, Miller JD,
  Russell MW. <strong><a href="../downloads/Ganz_InitialComboTx.pdf">Initial combination therapy with infliximab versus
  sequential DMARD monotherapy: a cost-effectiveness model based on the BeST
  study.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
 <p>
  Ganz ML, Smalarz AM, Anger JT, Krupski TL,
  Hu JC, Wittrup-Jensen KU, Pashos CL. <strong><a href="../downloads/Ganz_CostofOAB.pdf">Cost of overactive bladder in the United States.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.   </p>
 <p>
  Zhao Y, Boulanger L, Wu N, Lamothe K,
  Russell MW. <strong>Healthcare resource use and costs among patients
  with diabetic neuropathic pain in the one-year following duloxetine therapy:
  is initial dosing a significant factor?</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.   </p>
 <p>
  Brown TM, Lee WC, Joshi AV, Pashos CL. <strong><a href="../downloads/Brown_HRQL_Hemophilia.pdf">Health-related quality of life and productivity
  among hemophilia patients with inhibitors.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008.   </p>
 <p>
  Larholt K, Burton T, Boulanger L, et al. <strong><a href="../downloads/Larholt_TransfusionOutcomesASCOMay08.pdf">Transfusion outcomes in erythropoiesis-stimulating
  agent (ESA)-treated cancer chemotherapy patients based on achieved hemoglobin
  (Hb) levels.</a></strong> American Society of Clinical Oncology, 44th Annual Meeting, Chicago, IL, May 30-June 3, 2008.   </p>
 <p>
  Ganz ML, Pashos CL, Joshi AV, Wang Q, Lee
  WC, Wilke CT. <strong><a href="../downloads/Ganz_ClinicalandEconomicOutcomesMay08.pdf">Clinical and economic outcomes associated with
  bleeding during coronary artery bypass graft surgery among elderly Americans.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.   </p>
 <p>
  Burton T, Larholt K, Hoaglin D, Pashos CL,
  Bookhart B, Corral M, McKenzie RS, Tak Piech, C. <strong><a href="../downloads/Burton_CllinicalOutcomesMay08.pdf">Clinical outcomes and drug cost in
  erythropoiesis-stimulating agent (ESA)-treated cancer chemotherapy patients
  initiated with baseline (BL) hemoglobin.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
 <p>
  Lee WC, Brown M, Joshi AV, Foster T,
  Pashos CL. <strong><a href="../downloads/Brown_Caregivers.pdf">Patient- and caregiver-reported preferences for characteristics of treatments for hemophilia.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.   </p>
 <p>
  Lee WC, Brown M, Joshi AV, Foster T,
  Pashos CL. <strong><a href="../downloads/Brown_HRQL_Inhibitors.pdf">Health-related quality of life of patients with
  hemophilia and inhibitors.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.   </p>
 <p>
  Gao X, Shah S, Reddy P, Gondek K, Pashos
  CL. <strong><a href="../downloads/Gao_EconomicEvaluationMay08.pdf">Economic evaluation of sorafenib versus best
  supportive care in advanced renal cell carcinoma: an updated
  cost-effectiveness analysis.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
 <p>
  Boulanger L, Doan J, Pashos CL. <strong><a href="../downloads/Boulanger_SubstanceAbuseMay08.pdf">Substance abuse among patients diagnosed with
  insomnia.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
 <p>
  Boulanger L, Mody R, Bao Y, Ancukiewicz V,
  Kothari-Talwar S, Russell MW. <strong>Does the dosing frequency of proton pump inhibitors
  (PPIs) affect subsequent resource utilization and costs among patients
  diagnosed with gastroesophageal reflux disease (GERD)?</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.   </p>
 <p>
  Lee WC, Pickard S, Wilke C, Joshi AV, Yeh
  YC, Wang Q, Pashos CL. <strong>Economic impact of stroke-related comorbid
  conditions on the treatment of stroke: an analysis of Medicare beneficiaries
  in the United States.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.   </p>
 <p>
  Gao X, Spalding JR, Denevich S, Reddy P. <strong><a href="../downloads/Gao_GenderDisparitiesMay08.pdf">Gender disparities in the utilization of myocardial
  perfusion imaging.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
 <p>
  Boulanger L, Zhao Y, Bao Y, Cai C, Ye W,
  Russell, MW. <strong>Factors associated with healthcare costs among
  elderly patients with diabetic neuropathy. </strong>International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008.   </p>
 <p>
  Caloyeras JP, Wang C, Bauer L, Lee WC,
  Lanius V, Gondek K. <strong><a href="../downloads/Caloyeras_CostUtilityInterferonMay08.pdf">Cost-utility of Interferon Beta-1b in the treatment
  of patients with a clinically isolated syndrome suggestive of multiple
  sclerosis.</a> </strong>International Society for Pharmacoeconomics and
  Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
 <p>
  Larholt K et al. <strong>Transfusion outcomes among oncology patients
  initiated with Erythropoiesis-Stimulating Agents (ESAs) at baseline
  hemoglobin (Hb) of &lt;10 v 10- 11 g/dL: Observational data from the Dosing
  and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry.</strong> Community Oncology Conference,  Washington, DC, February 1-3, 2008.   </p>
 <p>
  Larholt K et al. <strong><a href="../downloads/Larholt_HemoLevelsFeb08.pdf">Hemoglobin (Hb) levels prior to blood transfusions
  in oncology patients receiving chemotherapy and Erythropoiesis-Stimulating
  Agents (ESAs): Observational Data from the Dosing and Outcomes Study of
  Erythropoiesis-Stimulating Therapies (DOSE) Registry.</a></strong> Community Oncology Conference,  Washington, DC, February 1-3, 2008. </p>
 <p class="backtotop"><a href="#top">back to top</a></p>
 
 <a name="2007"></a>
 <h2>2007</h2>
 <p>
  Balu S, Dutcher S, Lee WC, Joshi AV, Bilde
  L, Booth F, Pashos CL. <strong>Characterization, risk factors, clinical outcomes,
  and economic consequences of bleeding associated with cardiac surgery: A
  systematic literature review.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007.   </p>
 <p>
  Lee WC, Joshi AV, Pashos CL. <strong>Best-worst case scaling in discrete choice
  experiments: An application in a rare disease population.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007.   </p>
 <p>
  Balu S, Lee WC, Arondekar B, Horblyuk R,
  Pashos CL. <strong>Economic analysis of add-on therapy with
  thiazolidinedione (TZD) versus insulin (INS) to metformin (MET) monotherapy.</strong> American Diabetes Association, 67th Scientific Sessions, Chicago, IL, June 22-26, 2007.   </p>
 <p>
  Balu S, Arondekar B, Lee WC, Horblyuk R,
  Pashos CL. <strong>Budgetary impact of thiazolidinedione (TZD) add-on
  therapy relative to insulin (INS) add-on therapy in individuals treated with
  sulfonylureas (SU): A third party payer's perspective. </strong>American Diabetes Association, 67th Scientific Sessions, Chicago, IL, June 22-26, 2007.   </p>
 <p>
  Pashos CL, Wang Q, Larholt K, Bookhart B,
  McKenzie RS, Piech CT. <strong><a href="../downloads/Pashos_DrugCostConsiderationsJune07.pdf">Drug cost considerations for erythroprietic
  stimulating therapies (ESTs) agents in patients initiated at FDA-approved
  dosing: Results from practice patterns in a prospective observational study.</a></strong> Hematology Oncology Pharmacy Association (HOPA), 3rd Annual Conference, Denver, CO, June 14-16, 2007. </p>
 <p>
  Cai QC, Sullivan P, Yeh YC, Russell M. <strong><a href="../downloads/Cai_Assessing12ASCOJune07.pdf">Assessing 12 or more lymph nodes increases the
  proportion of stage III disease in colorectal cancer (CRC): Evidence from the
  Surveillance, Epidemiology and End Results (SEER) cancer registry.</a></strong> American Society of Clinical Oncology, 43rd Annual Meeting, Chicago, IL, June 1-5, 2007. </p>
 <p>
  Yeh YC, Cai QC, Chao J, Russell MW. <strong><a href="../downloads/Yeh_More AggressiveASCOJune07.pdf">Is more aggressive lymph node assessment associated
  with improved survival in stage II-III colorectal cancer? Evidence from the
  Surveillance, Epidemiology and End Results (SEER) cancer registry.</a> </strong>American Society of Clinical Oncology, 43rd Annual Meeting, Chicago, IL, June 1-5, 2007. </p>
 <p>
  Lee WC, Balu S, Cobden D, Joshi AV, Pashos
  CL. <strong><a href="../downloads/Lee_CopaymentLeveMay07.pdf">Co-payment level and medication adherence in type 2
  diabetes patients managed with insulin aspart pen therapy.</a> </strong>International Society for Pharmacoeconomics and
  Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
 <p>
  Balu S, Lee WC, Cobden D, Joshi AV, Pashos
  CL.<strong> <a href="../downloads/Balu_ImpactofInitiatingMay07.pdf">Impact of initiating or converting to treatment with
  an insulin aspart analog pen on medication adherence in type 2 diabetes
  patients on vial/syringe insulin.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
 <p>
  Balu S, Dutcher S, Lee WC, Cobden D, Joshi
  AV, Pashos CL. <strong><a href="../downloads/Balu_EpidemiologyEconomicBurdenMay07.pdf">Epidemiology and economic burden of stroke-related
  risk factors: A systematic literature review. </a></strong>International Society for Pharmacoeconomics and
  Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
 <p>
  Boulanger L, Miller JD, MacEachern L,
  Reddy P, Russell MW, Pashos CL. <strong><a href="../downloads/Boulanger_PrevalenceCachexiaMay07.pdf">Prevalance of cachexia (wasting syndrome) diagnosis
  and treatment among patients with HIV/AIDS: A medical claims database
  analysis.</a> </strong>International Society for Pharmacoeconomics and
  Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
 <p>
  Pashos CL, Wang Q, Larholt K, Bookhart B,
  McKenzie RS, Piech CT. <strong><a href="../downloads/Pashos_DrugCostConsiderationsJune07.pdf">Drug cost considerations for erythroprietic
  stimulating therapies (ESTs) agents in patients initiated at FDA-approved
  dosing: Results from practice patterns in a prospective observational study.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.   </p>
 <p>
  Boulanger L, Brown JS. <strong>Methodological considerations in conducting cost of
  illness studies employing large administrative claim databases.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007.   </p>
 <p>
  Lee WC, Yeh YC, Atzinger C, Pashos CL. <strong><a href="../downloads/Lee_ColonoscopyScreeningDDWMay07.pdf">Clinical and economic impact of increased
  colonoscopy screening in the United States: A computer simulation of a Markov
  process.</a></strong> Digestive Disease Week, Annual Meeting, Washington, DC, May 19-24, 2007. </p>
 <p>
  Lee WC, Balu S, Cobden D, Joshi AV, Pashos
  CL. <strong>Medication adherence and the health economic impact
  of anti-diabetic therapy conversion to an insulin analog pen device among
  type 2 diabetes patients.</strong> Academy of Managed Care Pharmacy, 19th Annual Meeting, San Diego, CA, April 11-14, 2007.   </p>
 <p class="backtotop"><a href="#top">back to top</a></p>
 
 <a name="2006"></a>
 <h2>2006</h2>
 <p>
  Chen E, Peake C, Buscaino E, Forlenza J,
  Bookhart B, McKenzie S. <strong><a href="../downloads/Chen_HematologicOutcomesDec06.pdf">Hematologic outcomes and erythropoiesis-stimulating
  therapy costs in Epoetin Alfa (EPO) and Darbepoetin Alfa (DARB)-treated
  cancer patients:  Results of the Dosing and Outcomes Study of
  Erythropoiesis-Stimulating Therapies (DOSE) Registry.</a></strong> American Society of Hematology, 48th Annual Meeting and Exposition, Orlando, FL, December 9-12, 2006. </p>
 <p>
  Wang Q, Larholt K, Pashos C, Forlenza J,
  Bookhart B, McKenzie S. <strong><a href="../downloads/Wang_EarlyHemoglobinDec06.pdf">Early hemoglobin response to
  erythropoiesis-stimulating therapies (ESTs) and outcomes in cancer patients
  with anemia: Results from a prospective, observational study.</a></strong> American Society of Hematology, 48th Annual Meeting and Exposition, Orlando, FL, December 9-12, 2006.   </p>
 <p>
  Lee WC, Balu S, Cobden D, Joshi AV, Pashos
  CL.<a href="../downloads/Lee_ImprovingAdherenceIDFDec06.pdf"> <strong>Improving medication adherence for type 2 diabetes
  patients: Effects of an analog insulin pen device.</strong> </a>International Diabetes Federation, 19th Annual Meeting, Capetown, South Africa, December 3-7, 2006. </p>
 <p>
  Lee WC, Cobden D, Balu S, Joshi AV, Pashos
  CL. <strong><a href="../downloads/Lee_ReducingHypoNov06.pdf">Reducing hypoglycemic events, costs and associated
  resource utilization in type 2 diabetes patients with conversion to an analog
  insulin pen device.</a></strong> Diabetes Technology Society, 6th Annual Meeting, Atlanta, GA, November 2-4, 2006.   </p>
 <p>
  Lee WC, Cobden D, Balu S, Joshi AV, Pashos
  CL. <strong><a href="../downloads/Lee_InsulinAdministrationNov06.pdf">Insulin administration with an analog pen device:
  Effect on medication adherence in type 2 diabetes patients.</a></strong> Diabetes Technology Society, 6th Annual Meeting, Atlanta, GA, November 2-4, 2006. </p>
 <p>
  Lee WC, Balu S, Cobden D, Joshi AV, Pashos
  CL. <strong>Insulin therapy among type 2 diabetes patients:
  Impact of conversion to a pen device on adherence, hypoglycemic events, and
  costs.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.   </p>
 <p>
  Reddy P, Boci K, Charbonneau C. <strong><a href="../downloads/Reddy_GISTOct2006.pdf">The epidemiologic, health-related quality of life,
  and economic burden of gastrointestinal stromal tumors.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.   </p>
 <p>
  Banks J, Gupta K, Balu S, Chen E,
  Komatsuzaki Y, Charbonneau, Pashos CL. <strong>The epidemiologic, humanistic and economic burden of
  patients with metastatic renal cell carcinoma.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.   </p>
 <p>
  Lee WC, Joshi AV, Brown M, Hadker N,
  Sumner M, Pashos CL. <strong><a href="../downloads/Lee_CoagulationOct2006.pdf">Physicians’ preferences toward coagulation factor
  concentrates in the treatment of hemophilia patients with inhibitors: A
  discrete choice experiment.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006. </p>
 <p>
  Balu S, Lee WC, Joshi AV, Cobden D, Pashos
  CL. <strong><a href="../downloads/Balu_AtrophicMay06.pdf">Treatment duration for atrophic vaginitis: Clinical
  trials versus “the real world”.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.   </p>
 <p>
  Balu S, Lee WC, Joshi AV, Cobden D, Pashos
  CL. <strong>Underutilization of vaginal estrogen therapy in a
  managed care setting.</strong> North American Menopause Society, 17th Annual Meeting, Nashville, TN, October 11-14, 2006.   </p>
 <p>
  Lee WC, Wang Q, Balu S, Joshi AV, Cobden
  D, Pashos CL. <strong>Treatment duration and adherence to vaginal estrogen
  therapy in patients receiving vaginal tablets versus vaginal creams in a
  managed care setting. </strong>North American Menopause Society, 17th Annual Meeting, Nashville, TN, October 11-14, 2006.   </p>
 <p>
  Gao X, Sato R, Nab H, Singh A. <strong><a href="../downloads/Gao_CostEffectivenessJune06.pdf">Cost-effectiveness of TNF inhibitors in the
  treatment of rheumatoid arthritis using radiographic progression as the
  effectiveness measure in the Netherlands.</a></strong> European Congress of Rheumatology, Annual Meeting, Amsterdam, Netherlands, June 21-24, 2006.   </p>
 <p>
  Gao X, Reddy P, Dhanda R, Gondek K, Yeh
  YC, Stadler W, Jonasch E. <strong><a href="../downloads/Gao_CESorafenibASCOJune06.pdf">Cost-effectiveness of sorafenib versus best
  supportive care in advanced renal cell carcinoma.</a> </strong>American Society of Clinical Oncology,  Annual Meeting, Atlanta, GA, June 2-6, 2006. </p>
 <p>
  Memisoglu A, Peake C, Buscaino E. <strong>Dosing and Outcomes Study of
  Erythropoiesis-Stimulating Therapies (D.O.S.E.) Registry: Analysis of
  outcomes and costs of epoetin alfa (EPO) and darbepoetin alfa (DARB)
  treatment in cancer patients.</strong> American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, June 2-6, 2006.   </p>
 <p>
  Anger JT, Litwin, MS, Wang Q, Chen E,
  Pashos CL, Rodríguez LV. <strong>Racial disparities in the surgical management of
  stress incontinence among female Medicare beneficiaries. </strong>American Urological Association, Annual Meeting,  Atlanta, GA, May 20-25, 2006.   </p>
 <p>
  Anger JT, Rodríguez LV, Wang Q, Pashos CL,
  Litwin MS. <strong>High volume providers perform more prolapse repairs
  at the time of sling surgery.</strong> American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.   </p>
 <p>
  Anger JT, Litwin MS, Wang Q, Pashos CL,
  Rodríguez LV. <strong>Complications of sling surgery among female Medicare
  beneficiaries.</strong> American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.   </p>
 <p>
  Anger JT, Litwin MS, Wang Q, Pashos CL,
  Rodríguez LV. <strong>Variations in stress incontinence and prolapse
  management by surgeon specialty.</strong> American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006.   </p>
 <p>
  Lee WC, Balu S, Cobden D, Joshi, AV, Pashos CL. <strong><a href="../downloads/Lee_AdherenceMay06.pdf">A systematic review of adherence with diabetes
  treatment and impact of non-adherence on healthcare costs.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006. </p>
 <p>
  Balu S, Cobden D. Joshi AV, Lee WC, Pashos
  CL. <strong><a href="../downloads/Balu_SystematicReviewMay06.pdf">A systematic review of atrophic vaginitis treatment,
  duration of therapy, and healthcare costs.</a></strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006.   </p>
 <p>
 Chavez Y, Atzinger C, Lee WC, Pashos CL. <strong>Gaps in the economic evaluation of prostate cancer.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006.   </p>
 <p>
  Gao X, Outley JK, Botteman M, Spalding J,
  Simon JA, Pashos CL. <strong>The economic burden of endometriosis.</strong> American College of Obstetrics and Gynecology, Annual Meeting, Washington, DC, May 6-10, 2006.   </p>
 <p>
  Anger JT, Rodríguez LV, Wang Q, Pashos CL,
  Litwin MS. <strong>High volume providers perform more prolapse repairs
  at the time of sling surgery.</strong> Society for Urodynamics and Female Urology,
  International Society of Pelvic Neuromodulation, Genito-Urinary
  Reconstructive Surgery Society, Geriatric Urologic Society, and International
  Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006.   </p>
 <p>
  Anger JT, Litwin MS, Wang Q, Pashos CL,
  Rodríguez LV. <strong>Complications of sling surgery among female Medicare
  beneficiaries.</strong> Society for Urodynamics and Female Urology,
  International Society of Pelvic Neuromodulation, Genito-Urinary
  Reconstructive Surgery Society, Geriatric Urologic Society, and International
  Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006.   </p>
 <p>
  Anger JT, Litwin MS, Wang Q, Pashos CL,
  Rodríguez LV. <strong>Variations in stress incontinence and prolapse
  management by surgeon specialty.</strong> Society for Urodynamics and Female Urology,
  International Society of Pelvic Neuromodulation, Genito-Urinary
  Reconstructive Surgery Society, Geriatric Urologic Society, and International
  Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006.   </p>
 <p class="backtotop"><a href="#top">back to top</a></p>
 
 <a name="2005"></a>
 <h2>2005</h2>
 <p>
  Cobden D, Nicklasson L, Pashos C, Lee WC,
  Conway D. <strong>Economic analysis of the direct and indirect
  post-exposure burden associated with needlestick injury in nurses treating
  patients with diabetes mellitus.</strong> American Society of Health-System Pharmacists, 40th Mid-year Clinical Meeting, Las Vegas, NV, December 4-8, 2005.   </p>
 <p>
  Lee WC, Hoffman MS, Arcona S, D’Souza J,
  Wang Q, Pashos CL. <strong>Cost of treatment for patients with partial seizure
  disorder who are refractory.</strong> American Epilepsy Association, 59th Annual Meeting, Washington, DC, December 2-6, 2005.   </p>
 <p>
  Lee WC, Memisoglu A, Pashos CL. <strong>Challenges of designing prospective and
  retrospective compliance studies. </strong>International Society for Pharmacoeconomics and
  Outcomes Research, 8th Annual European Congress, Florence, Italy, November 6-8, 2005.   </p>
 <p>
  Lee WC, Christensen MC, Joshi AV, Wang Q,
  Pashos CL. <strong>Long-term survival among Medicare beneficiaries with
  intracranial hemorrhage.</strong> 18th World Congress of Neurology,  Sydney, Australia, November 5-11, 2005.   </p>
 <p>
  Yeh Y, Schaefer C, Kutikova L, Edgell E,
  Husbands C, Szende A. <strong>Quality of life in hepatocellular carcinoma: A
  review of instruments, disease burden, and quality of life outcomes.</strong> International Society for Quality of Life Research
  (ISOQOL), Annual Meeting, San Francisco, CA, October 19-22, 2005.   </p>
 <p>
  Duff S, Yeh Y, Yu E, Woolley J. <strong>The economic impact of etanercept and infliximab
  treatment in ankylosing spondylitis.</strong> European Congress of Rheumatology, Annual Meeting, Vienna, Austria, June 8-11, 2005.   </p>
 <p>
  Lee WC. <strong>Cost of therapy for ARV naïve HIV-infected patients:
  Fosamprenavir/Ritonavir versus Nelfinavir.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005.   </p>
 <p>
  Botteman MF, Ozminkowski RJ, Wang S,
  Pashos CL, Foley DJ, Schaefer K. <strong>Cost effectiveness of longer-term treatment with
  eszopiclone 3mg in adults with primary insomnia.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005.   </p>
 <p>
  Pashos CL, Lee JM, Botteman MF, Nicklasson
  L, Cobden D. <strong>Needlestick injury in acute care nurses caring for
  patients with diabetes mellitus: A retrospective study.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005.   </p>
 <p class="backtotop"><a href="#top">back to top</a></p>
 
 <a name="2004"></a>
 <h2>2004</h2>
 <p>
  Lee WC, Arcona S, Hoffmann M, Wang Q,
  Stephens J, Pashos CL. <strong>Cost associated with persistency among patients with
  partial seizure disorder switching to oxcarbazepine monotherapy.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 7th Annual European Congress, Hamburg, Germany, October 24-26, 2004.   </p>
 <p>
  Lee WC, Arcona S, Hoffmann M, Wang Q,
  Stephens J, Pashos CL. <strong>Effect of comorbidities on medical care use and cost
  among patients with partial seizure disorder.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 7th Annual European Congress, Hamburg, Germany, October 24-26, 2004.   </p>
 <p>
  Smith M, Lee WC, Krupski T, Brandman J,
  Wang Q, Botteman M, Pashos CL, Litwin M. <strong>Association between androgen deprivation therapy and
  fracture risk: A population-based cohort study in men with non-metastatic
  prostate cancer. </strong>American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, June 5-8, 2004.   </p>
 <p>
  Krupski T, Smith M, Lee WC, Pashos C,
  Brandman J, Wang Q, Botteman M, Litwin M. <strong>Profile of men with prostate cancer on androgen
  deprivation therapy at greatest risk of bone complications.</strong> American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, June 5-8, 2004.   </p>
 <p>
  Lee WC, Tran KT, Stephens JM, Dirani RG,
  Pashos CL. <strong>Adherence to oral diabetic drug regimen by racial
  group in the Texas Medicaid population. </strong>American Diabetes Association, 64th Annual Scientific Sessions, Orange County Convention Center, Orlando, FL, June 4-8, 2004.   </p>
 <p>
  Grad O, Davis J, Vichare R, Mucha L,
  Pashos C, Fastenau J, McKenzie RS, Piech CT. <strong>Dosing and Outcomes Study of
  Erythropoiesis-stimulating Therapies - D.O.S.E.</strong> Multinational Association of Supportive Care in
  Cancer, Annual Meeting, New Orleans, LA, June 2004.   </p>
 <p>
  Lee WC, Pashos CL. <strong>Using the difference in difference method to
  understand outcomes in prostate cancer. </strong>International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Chavez YE, Lee WC, Botteman MF, Pashos CL. <strong>Cost-effectiveness of diagnostic, staging and
  treatment options for melanoma.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Lee WC, Stephens JM, Tran KT, Wang Q,
  Dirani RG, Pashos CL. <strong>The economic burden of type 2 diabetes management by
  ethnic group in the Texas Medicaid population.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Edwards N, Rupnow M, Pashos CL, Botteman
  MF, Locklear J, Diamond R. <strong>Cost-effectiveness evaluation of long-acting
  risperidone injection.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Tran KT, Stephens JM, Gold KF, Kimura A,
  Pashos CL, Muenzer J. <strong>Development and pilot testing of the Hunter Syndrome
  &#8211; Functional Outcomes for Clinical Understanding Scale: An instrument
  to assess functional health in Hunter Syndrome.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Tran KT, Gold KF, Stephens JM, Kimura A,
  Pashos CL, Muenzer J. <strong>Validation of the Hunter Syndrome &#8211; Functional
  Outcomes for Clinical Understanding Scale.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Lee WC, Barlas S, Gold KF, Duong P, Madoo
  L, Reddy P, Pashos CL. <strong>Anticipated pain prior to surgery compared to actual
  pain in patients undergoing outpatient arthroscopic knee procedures.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Botteman MF, Lowe FC, Naslund M, Sollano
  J, Pashos CL, Litwin M. <strong>A cost comparison analysis of two clinically
  uroselective alpha blockers in the treatment of benign prostatic hyperplasia.</strong> International Society for Pharmacoeconomics and
  Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004.   </p>
 <p>
  Krupski TL, Smith M, Lee WC, Pashos C,
  Brandman J, Wang Q, Botteman M, Litwin MS. <strong>Fracture risk in men with prostate cancer on
  androgen deprivation therapy. </strong>American Urological Association, 99th Annual Meeting, San Francisco, CA, May 8-13, 2004.   </p>
 <p>
  Niren N, Grad O, Sung JC, Law A, Shah NP,
  Wang Q. <strong>Impact of atopic dermatitis treatment on quality of
  life &#8211; Results from the findings in atopic children with eczema study.</strong> American Academy of Dermatology, Annual Meeting, Washington, DC, February 6-11, 2004.   </p>

  </div>
  
 <!-- FOOTER -->
  <div id="footer">
  &copy; 2009 Abt Bio-Pharma Solutions, Inc. All rights reserved. | <a href="../privacy/index.html">Privacy Statement</a> | <a href="../privacy/safe.html">Safe Harbor Policy</a></div>
  </div><!--close container-->

<!-- POPUP MENUS -->
<div id="popupabout" class="popupmenu">
<p><a href="../about/index.html">About ABS</a></p>
<p><a href="../about/executive.html">Executive Management</a></p>
<p><a href="../about/our.html">Our Locations</a></p></div>

<div id="popupadvantage" class="popupmenu">
<p><a href="../advantage/index.html">Our Advantage</a></p>
<p><a href="../advantage/approach.html">Approach</a></p>
<p><a href="../advantage/experience.html">Experience</a></p></div>

<div id="popupservices" class="popupmenu">
<p><a href="../services/biometrics.html">Biometrics</a></p>
<p><a href="../services/clinical.html">Clinical Trials</a></p>
<p><a href="../services/health.html">Health Economics & Outcomes Research</a></p>
<p><a href="../services/postmarketing.html">Registries and Observational Studies</a></p>
<p><a href="../services/strategic.html">Strategic Commercialization Services</a></p></div>

<div id="popuppub" class="popupmenu">
<p><a href="../pub/publications.html">Publications</a></p>
<p><a href="../pub/presentations.html">Presentations</a></p></div>

<div id="popupnews" class="popupmenu">
<p><a href="../news/index.html">News</a></p>
<p><a href="../news/events.html">Events</a></p></div>

<div id="popupcareers" class="popupmenu">
<p><a href="../careers/index.html">Employment at ABS</a></p>
<p><a href="../careers/current.html">Current Opportunities</a></p>
<p><a href="../careers/benefits.html">Benefits</a></p></div>
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-7436309-1");
pageTracker._trackPageview();
} catch(err) {}</script> 
</body>
</html>

Anon7 - 2021